Tarsus Pharmaceuticals Inc TARS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	227.86M	211.21M	188.93M	268.33M	265.49M	349.28M	376.84M	376.3M
Total Current Assets	225.38M	208.65M	183.48M	259.28M	256.13M	340.72M	362.59M	357.12M
Cash and Equivalents	71.66M	66M	106.77M	226.67M	224.95M	193.71M	181.1M	176.21M
Total Non-Current Assets	3.45M	3.76M	6.99M	10.67M	10.83M	9.89M	16.5M	21.58M
Total Liabilities	34.96M	37.81M	41.2M	54.67M	68.5M	74.07M	124.6M	138.82M
Total Current Liabilities	15.43M	13.26M	14.77M	23.25M	36.94M	42.53M	51.57M	65.87M
Total Non-Current Liabilities	38.97M	49.07M	51.04M	61.13M	61.39M	61.47M	144.61M	144.66M
Common Equity	5k	5k	5k	5k	5k	6k	6k	6k
Retained Earnings	-108.76M	-132.18M	-163.61M	-202.75M	-244.66M	-280.39M	-313.68M	-337.1M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	2.39M	58.32M	171.97M	178.91M	227.86M	265.49M
Total Current Assets	2.38M	58.03M	170.66M	175.95M	225.38M	256.13M
Cash and Equivalents	2.36M	57.95M	168.13M	171.33M	71.66M	224.95M
Total Non-Current Assets	-1.35M	-6.01M	165.98M	166.73M	192.9M	196.99M
Total Liabilities	179k	919k	5.99M	12.18M	34.96M	68.5M
Total Current Liabilities	179k	819k	5.39M	11.48M	15.43M	36.94M
Total Non-Current Liabilities	0	100k	605k	699k	38.97M	61.39M
Total Equity	-1.35M	-6.01M	165.98M	166.73M	192.9M	196.99M
Common Equity	1,000	2k	4k	4k	5k	5k
Retained Earnings	-1.36M	-6.03M	-32.85M	-46.67M	-108.76M	-244.66M